Global Circulating Biomarker for Liquid Biopsy Market Insights, Forecast to 2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Circulating Biomarker for Liquid Biopsy Revenue
• 1.4 Market by Type
  • 1.4.1 Global Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Circulating Tumor Cells (CTCs)
  • 1.4.3 Circulating Tumor DNA (ctDNA)
  • 1.4.4 Cell-Free DNA (cfDNA)
  • 1.4.5 Extracellular Vesicles (EVs)
  • 1.4.6 Others
• 1.5 Market by Application
  • 1.5.1 Global Circulating Biomarker for Liquid Biopsy Market Share by Application: 2020 VS 2026
  • 1.5.2 Early Cancer Screening
  • 1.5.3 Therapy Selection
  • 1.5.4 Treatment Monitoring
  • 1.5.5 Recurrence Monitoring Orthopedics
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Circulating Biomarker for Liquid Biopsy Market Perspective (2015-2026)
• 2.2 Global Circulating Biomarker for Liquid Biopsy Growth Trends by Regions
  • 2.2.1 Circulating Biomarker for Liquid Biopsy Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Circulating Biomarker for Liquid Biopsy Historic Market Share by Regions (2015-2020)
  • 2.2.3 Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Circulating Biomarker for Liquid Biopsy Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Circulating Biomarker for Liquid Biopsy Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Circulating Biomarker for Liquid Biopsy Players by Market Size
  • 3.1.1 Global Top Circulating Biomarker for Liquid Biopsy Players by Revenue (2015-2020)
  • 3.1.2 Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Circulating Biomarker for Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Circulating Biomarker for Liquid Biopsy Market Concentration Ratio
  • 3.2.1 Global Circulating Biomarker for Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Circulating Biomarker for Liquid Biopsy Revenue in 2019
• 3.3 Circulating Biomarker for Liquid Biopsy Key Players Head office and Area Served
• 3.4 Key Players Circulating Biomarker for Liquid Biopsy Product Solution and Service
• 3.5 Date of Enter into Circulating Biomarker for Liquid Biopsy Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Circulating Biomarker for Liquid Biopsy Historic Market Size by Type (2015-2020)
• 4.2 Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020)
• 5.2 Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Circulating Biomarker for Liquid Biopsy Market Size (2015-2020)
• 6.2 Circulating Biomarker for Liquid Biopsy Key Players in North America (2019-2020)
• 6.3 North America Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020)
• 6.4 North America Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Circulating Biomarker for Liquid Biopsy Market Size (2015-2020)
• 7.2 Circulating Biomarker for Liquid Biopsy Key Players in Europe (2019-2020)
• 7.3 Europe Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020)
• 7.4 Europe Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020)

8 China

• 8.1 China Circulating Biomarker for Liquid Biopsy Market Size (2015-2020)
• 8.2 Circulating Biomarker for Liquid Biopsy Key Players in China (2019-2020)
• 8.3 China Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020)
• 8.4 China Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Circulating Biomarker for Liquid Biopsy Market Size (2015-2020)
• 9.2 Circulating Biomarker for Liquid Biopsy Key Players in Japan (2019-2020)
• 9.3 Japan Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020)
• 9.4 Japan Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size (2015-2020)
• 10.2 Circulating Biomarker for Liquid Biopsy Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020)
• 10.4 Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020)

11 India

• 11.1 India Circulating Biomarker for Liquid Biopsy Market Size (2015-2020)
• 11.2 Circulating Biomarker for Liquid Biopsy Key Players in India (2019-2020)
• 11.3 India Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020)
• 11.4 India Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Circulating Biomarker for Liquid Biopsy Market Size (2015-2020)
• 12.2 Circulating Biomarker for Liquid Biopsy Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020)
• 12.4 Central & South America Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Abbott Laboratories
  • 13.1.1 Abbott Laboratories Company Details
  • 13.1.2 Abbott Laboratories Business Overview
  • 13.1.3 Abbott Laboratories Circulating Biomarker for Liquid Biopsy Introduction
  • 13.1.4 Abbott Laboratories Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020))
  • 13.1.5 Abbott Laboratories Recent Development
• 13.2 Becton, Dickinson and Company
  • 13.2.1 Becton, Dickinson and Company Company Details
  • 13.2.2 Becton, Dickinson and Company Business Overview
  • 13.2.3 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Introduction
  • 13.2.4 Becton, Dickinson and Company Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
  • 13.2.5 Becton, Dickinson and Company Recent Development
• 13.3 GE Healthcare
  • 13.3.1 GE Healthcare Company Details
  • 13.3.2 GE Healthcare Business Overview
  • 13.3.3 GE Healthcare Circulating Biomarker for Liquid Biopsy Introduction
  • 13.3.4 GE Healthcare Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
  • 13.3.5 GE Healthcare Recent Development
• 13.4 Epigenomics AG
  • 13.4.1 Epigenomics AG Company Details
  • 13.4.2 Epigenomics AG Business Overview
  • 13.4.3 Epigenomics AG Circulating Biomarker for Liquid Biopsy Introduction
  • 13.4.4 Epigenomics AG Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
  • 13.4.5 Epigenomics AG Recent Development
• 13.5 Agilent Technologies
  • 13.5.1 Agilent Technologies Company Details
  • 13.5.2 Agilent Technologies Business Overview
  • 13.5.3 Agilent Technologies Circulating Biomarker for Liquid Biopsy Introduction
  • 13.5.4 Agilent Technologies Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
  • 13.5.5 Agilent Technologies Recent Development
• 13.6 Biocept
  • 13.6.1 Biocept Company Details
  • 13.6.2 Biocept Business Overview
  • 13.6.3 Biocept Circulating Biomarker for Liquid Biopsy Introduction
  • 13.6.4 Biocept Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
  • 13.6.5 Biocept Recent Development
• 13.7 Affymetrix
  • 13.7.1 Affymetrix Company Details
  • 13.7.2 Affymetrix Business Overview
  • 13.7.3 Affymetrix Circulating Biomarker for Liquid Biopsy Introduction
  • 13.7.4 Affymetrix Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
  • 13.7.5 Affymetrix Recent Development
• 13.8 Fluxion Biosciences
  • 13.8.1 Fluxion Biosciences Company Details
  • 13.8.2 Fluxion Biosciences Business Overview
  • 13.8.3 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Introduction
  • 13.8.4 Fluxion Biosciences Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
  • 13.8.5 Fluxion Biosciences Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer